News
The Post Office has announced plans to sell off its remaining directly-owned branches, putting around 1,000 employees at risk ...
Eisai/Biogen’s Leqembi (lecanemab) was fully approved in the US in July 2023, and Eli Lilly’s Kisunla (donanemab) in July ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results